Table 1b Characteristics between subclinical ICL patients with high and low baPWV
Total (n=55) | Low baPWV (n=25) | High baPWV (n=30) | P-value | |
|---|---|---|---|---|
Mean age–year | 70.9±10.7 | 65.9±10.1 | 75.0±9.3 | 0.001 |
Male sex–no. (%) | 44 (80.0) | 22 (88.0) | 22 (73.3) | 0.31 |
Mean BMI | 23.1±3.1 | 23.1±2.8 | 23.1±3.5 | 0.98 |
ACS–no. (%) | 17 (31.5) | 5 (20.0) | 12 (41.4) | 0.14 |
Hypertension–no. (%) | 42 (76.4) | 18 (72.0) | 24 (80.0) | 0.54 |
Systolic BP | 136±22 | 133±23 | 138±20 | 0.36 |
Diastolic BP | 72±13 | 73±15 | 72±12 | 0.79 |
Diabetes–no. (%) | 29 (52.7) | 14 (56.0) | 15 (50.0) | 0.79 |
Dyslipidemia–no. (%) | 37 (67.3) | 17 (68.0) | 20 (66.7) | 1.0 |
Family history of CAD–no. (%) | 19 (34.5) | 10 (40.0) | 9 (30.0) | 0.57 |
Peripheral arterial disease–no. (%) | 14 (25.5) | 6 (24.0) | 8 (26.7) | 1.0 |
Chronic kidney disease–no. (%) | 31 (56.4) | 9 (36.0) | 22 (73.3) | 0.007 |
Current tobacco use–no. (%) | 8 (14.5) | 5 (20.0) | 3 (10.0) | 0.45 |
Previous MI–no. (%) | 8 (14.5) | 4 (16.0) | 4 (13.3) | 1.0 |
Coronary lesions–no. (%) | ||||
Single lesions | 16 (29.1) | 6 (24.0) | 10 (33.3) | 0.56 |
Triple or LMT lesions | 15 (27.3) | 8 (32.0) | 7 (23.3) | 0.55 |
Medication on discharge–no. (%) | ||||
Beta-blocker | 45 (81.8) | 22 (88.0) | 23 (76.7) | 0.32 |
ACE inhibitor or ARB | 36 (65.5) | 15 (60.0) | 21 (70.0) | 0.57 |
Statin | 49 (89.1) | 24 (96.0) | 25 (83.3) | 0.20 |
